Aim: To investigate anxiety levels and patient perception associated with supraventricular tachycardia (SVT); investigate anxiety levels and patient perception pre-and post-radiofrequency catheter ablation (RFCA); and explore any association between anxiety and patient perception with patient age and gender.
Introduction
Supraventricular tachycardia (SVT) encompasses a group of common paroxysmal tachyarrhythmias. SVT occurs in all age groups, and its mechanism varies depending on patient demographics. 1 Prevalence is around 2.25 per 1000 in the general population. 2 Atrioventricular nodal re-entrant tachycardia (AVNRT) is the commonest cause of paroxysmal SVT, accounting for 50-60% of diagnoses. 3, 4 It is more prevalent in young females. 5 The AV node usually has a single conducting pathway whereby impulses travel to reach the bundle of His and cause contraction of the ventricles of the heart.
Dual conduction pathways may coexist in some individuals and premature atrial impulses travelling along the secondary pathway may trigger episodes of AVNRT.
Other mechanisms of SVT include atrioventricular re-entrant tachycardia, which includes Wolff-Parkinson-White syndrome and atrial tachycardia; a rare mechanism occurring in individuals with complex or structural heart disease particularly due to iatrogenesis or digoxin toxicity. [6] [7] [8] Presentation of SVT can range from an asymptomatic presentation and anxiety to shortness of breath, syncope, and chest pain. Palpitations are present in 96% of presentations.
9,10
Although SVT is not usually life threatening, many patients suffer recurrent symptoms that have a significant
impact on their quality of life. Many have symptoms for a prolonged period of time before diagnosis. Episodes are commonly misdiagnosed as panic attacks. [11] [12] [13] Radiofrequency catheter ablation (RFCA) is the first-line therapy for many SVTs, usually performed as a day-case procedure using conscious sedation. The efficacy of RFCA exceeds that of medical therapy, with success rates of around 95%. 14 The procedure involves insertion of an ablation catheter, usually via the femoral vein, allowing for focal ablation of a critical component of the arrhythmic mechanismsuch as an accessory pathway -using heat generated from high frequency alternating current.
Hypothesis
We hypothesize that 1) patients with SVT experience high levels of anxiety during their index episode and many believe they are experiencing a cardiac event; 2) anxiety levels are greater in female patients; 3)
anxiety levels are greater in older patients; and 4) RFCA considerably reduces anxiety levels in patients with SVT. 
Follow-up and data collection
The mean follow-up period was 14 months 
Statistical analysis
Statistical analysis was conducted using SPSS software. Anxiety level during the index episode was divided into 4 categories: The mean anxiety experienced was compared with patients' thoughts prior to RFCA.
Results

Anxiety during index episode
Out of 141 patients, median anxiety during There was a significant association between age and anxiety during the first episode.
Older patients showed greater anxiety (p = The median anxiety level prior to RFCA was highest in patients afraid of complications and of being awake during the procedure.
Lack of information and fear of potential complications are known to cause high levels of anxiety. 22, 23 However, it could be argued that this is the case for any invasive procedure and not RFCA in particular.
There is a paucity of research regarding the difference in periprocedural anxiety among different invasive procedures. Many patients, however, mentioned previously undergoing invasive procedures where they had felt less anxious, and reported that the notion of being awake during a procedure which targeted a vital organ such as the heart caused them concern. Other patients were anxious due to the complexity of the procedure and the potential complications, which would be irreversible and require further interventions like pacemaker implantation. Anxiety levels prior to RFCA in this study were higher than anticipated, perhaps indicating a greater need for preprocedural explanation and reassurance.
Previous research has suggested including discussions of previous patient experiences or reassurance from the clinician prior to RFCA to alleviate patient anxiety. 24 The idea of catheters entering the heart and ablating tissue will seem bizarre to patients, and the complexity of RFCA may require a more 
Implications for practice and policy
Anxiety is an important cause of morbidity and increased utilization of medical care. It is important for medical students to appreciate the impact that psychopathology can have on pre-existing disease and its prognostic contribution to cardiovascular disease. 29 Identifying a demographic pattern in patients who present with severe anxiety after SVT will allow for more efficient psychopharmacological intervention. This study provides a basis for further study.
The ANOVA test was used in this study to determine associations between patient anxiety and patient perceptions during their index episode. For this to be possible, perceptions had to be divided into 2 categories. The division of patients' thoughts into binary values -"dangerous"
and "benign" -is potentially problematic.
This could be avoided in further studies by simplifying the question regarding perceptions and asking patients if they felt that they needed to go to the hospital or not, then determining an association with anxiety between the 2 groups using the Mann-Whitney test.
Conclusion
The psychological health of patients is an important factor to take into account as RFCA can significantly reduce patient anxiety.
Learning Points
What is already known?
 SVT is a common tachyarrhythmia that causes anxiety in many patients.
 Misinterpretation of episodes is common and many SVTs are misdiagnosed as panic attacks.
 Catheter ablation is the first-line treatment for SVTs and significantly reduces anxiety levels in patients.
What does this study add?
 This study explores patients' anxiety during their index episode of SVT and provides details of patients' perceptions of their first attacks.
 As anxiety is a common problem associated with SVT, exploring this aspect will hopefully lead to cardiologists providing more counselling and improving patient education during the time of referral and review and prior to the catheter ablation procedure.  Reducing anxiety in SVT patients will drastically lessen the severity of physical symptoms and improve quality of life.
APPENDIX PATIENT INFORMATION SHEET SUPRAVENTRICULAR MECHANISMS AND THEIR AGE AND GENDER DISTRIBUTION
You are being invited to take part in a research study. Before you decide, it is important for you to understand why this research is being done and what it will involve. Please take time to read the following information carefully and discuss it with others if you wish.
What is the purpose of this study and why have I been chosen?
You have been chosen out of a group of 180 patients because you have been seen in the cardiology clinic with an arrhythmia and have undergone ablation treatment. We are interested in hearing about your experience with your condition, both before and after your treatment.
This study is designed to assess how patients' lives are affected, both physically and psychosocially, by their condition.
Do I have to take part?
It is completely your choice whether or not to take part. If you do decide to join our study, you are still free to withdraw at any time and without giving a reason. A decision not to take part will not affect the standard of care you receive.
What will happen to me if I take part and what are the potential risks?
There is no risk involved in this study. Over the next few weeks, you will receive a phone call from us. We require around 10 minutes of your time, during which we will ask you to complete a short questionnaire over the phone. This questionnaire will assess your first experience of arrhythmia symptoms, how you felt at the time and your past medical history. It will also ask questions about your health, mood and experiences with your ablation treatment; both during and after the procedure. If you receive a call from us and feel that you do not have the time to answer questions at that moment, we would be happy to reschedule an interview.
Will my taking part in the study be kept confidential?
All information which is collected about you will be kept strictly confidential. Any information which leaves the hospital/surgery will have your name and address removed do that you cannot be recognised from it.
What will happen to the results of the study?
The results will form part of a research project which will be submitted to the University of Edinburgh Medical Faculty. It is hoped that the results will be submitted for publication to a medical journal. As stated above, all information will be kept anonymous.
The results of the study will be made available to you should you require further information Thank you for your consideration of this study Dr. xxx is a consultant Cardiologist who is available to advise you about the study and participation if you require more information, and is contactable through the Royal Infirmary of Edinburgh switchboard: (0131 242 1000)
(2) Structured Clinical Interview
How old were you when you had your first episode?
What was the first thing you thought when palpitation started?
How anxious did you feel during your first attack? (score of 0-10; 0 being not anxious at all and 10 being the most anxious you could be)
How 
